FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2290428590> ?p ?o ?g. }

• W2290428590 endingPage "669" @default.
• W2290428590 startingPage "661" @default.
• W2290428590 abstract "Abstract Targeting tumor-overexpressed EGFR with an antibody–drug conjugate (ADC) is an attractive therapeutic strategy; however, normal tissue expression represents a significant toxicity risk. The anti-EGFR antibody ABT-806 targets a unique tumor-specific epitope and exhibits minimal reactivity to EGFR in normal tissue, suggesting its suitability for the development of an ADC. We describe the binding properties and preclinical activity of ABT-414, an ABT-806 monomethyl auristatin F conjugate. In vitro, ABT-414 selectively kills tumor cells overexpressing wild-type or mutant forms of EGFR. ABT-414 inhibits the growth of xenograft tumors with high EGFR expression and causes complete regressions and cures in the most sensitive models. Tumor growth inhibition is also observed in tumor models with EGFR mutations, including activating mutations and those with the exon 2–7 deletion [EGFR variant III (EGFRvIII)], commonly found in glioblastoma multiforme. ABT-414 exhibits potent cytotoxicity against glioblastoma multiforme patient-derived xenograft models expressing either wild-type EGFR or EGFRvIII, with sustained regressions and cures observed at clinically relevant doses. ABT-414 also combines with standard-of-care treatment of radiation and temozolomide, providing significant therapeutic benefit in a glioblastoma multiforme xenograft model. On the basis of these results, ABT-414 has advanced to phase I/II clinical trials, and objective responses have been observed in patients with both amplified wild-type and EGFRvIII-expressing tumors. Mol Cancer Ther; 15(4); 661–9. ©2016 AACR." @default.
• W2290428590 created "2016-06-24" @default.
• W2290428590 creator A5002379868 @default.
• W2290428590 creator A5016707540 @default.
• W2290428590 creator A5021045769 @default.
• W2290428590 creator A5023133868 @default.
• W2290428590 creator A5026627782 @default.
• W2290428590 creator A5028407662 @default.
• W2290428590 creator A5031829020 @default.
• W2290428590 creator A5054105958 @default.
• W2290428590 creator A5054286201 @default.
• W2290428590 creator A5054613632 @default.
• W2290428590 creator A5060966004 @default.
• W2290428590 creator A5073796163 @default.
• W2290428590 creator A5078103055 @default.
• W2290428590 date "2016-04-01" @default.
• W2290428590 modified "2023-10-12" @default.
• W2290428590 title "ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope" @default.
• W2290428590 cites W1642119993 @default.
• W2290428590 cites W1939364580 @default.
• W2290428590 cites W1976041621 @default.
• W2290428590 cites W1979794702 @default.
• W2290428590 cites W1981219430 @default.
• W2290428590 cites W1982244230 @default.
• W2290428590 cites W1986241711 @default.
• W2290428590 cites W1986870171 @default.
• W2290428590 cites W2014036436 @default.
• W2290428590 cites W2014362060 @default.
• W2290428590 cites W2019300898 @default.
• W2290428590 cites W2019691808 @default.
• W2290428590 cites W2025606242 @default.
• W2290428590 cites W2031520822 @default.
• W2290428590 cites W2051363346 @default.
• W2290428590 cites W2052705131 @default.
• W2290428590 cites W2062627275 @default.
• W2290428590 cites W2093775484 @default.
• W2290428590 cites W2099797203 @default.
• W2290428590 cites W2124560587 @default.
• W2290428590 cites W2129944198 @default.
• W2290428590 cites W2134989772 @default.
• W2290428590 cites W2134992410 @default.
• W2290428590 cites W2136101268 @default.
• W2290428590 cites W2140122751 @default.
• W2290428590 cites W2140407529 @default.
• W2290428590 cites W2161879730 @default.
• W2290428590 cites W2167791214 @default.
• W2290428590 cites W2275877493 @default.
• W2290428590 cites W2466482857 @default.
• W2290428590 cites W2600769610 @default.
• W2290428590 cites W35847484 @default.
• W2290428590 cites W4230633371 @default.
• W2290428590 cites W4247253223 @default.
• W2290428590 doi "https://doi.org/10.1158/1535-7163.mct-15-0901" @default.
• W2290428590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26846818" @default.
• W2290428590 hasPublicationYear "2016" @default.
• W2290428590 type Work @default.
• W2290428590 sameAs 2290428590 @default.
• W2290428590 citedByCount "134" @default.
• W2290428590 countsByYear W22904285902016 @default.
• W2290428590 countsByYear W22904285902017 @default.
• W2290428590 countsByYear W22904285902018 @default.
• W2290428590 countsByYear W22904285902019 @default.
• W2290428590 countsByYear W22904285902020 @default.
• W2290428590 countsByYear W22904285902021 @default.
• W2290428590 countsByYear W22904285902022 @default.
• W2290428590 countsByYear W22904285902023 @default.
• W2290428590 crossrefType "journal-article" @default.
• W2290428590 hasAuthorship W2290428590A5002379868 @default.
• W2290428590 hasAuthorship W2290428590A5016707540 @default.
• W2290428590 hasAuthorship W2290428590A5021045769 @default.
• W2290428590 hasAuthorship W2290428590A5023133868 @default.
• W2290428590 hasAuthorship W2290428590A5026627782 @default.
• W2290428590 hasAuthorship W2290428590A5028407662 @default.
• W2290428590 hasAuthorship W2290428590A5031829020 @default.
• W2290428590 hasAuthorship W2290428590A5054105958 @default.
• W2290428590 hasAuthorship W2290428590A5054286201 @default.
• W2290428590 hasAuthorship W2290428590A5054613632 @default.
• W2290428590 hasAuthorship W2290428590A5060966004 @default.
• W2290428590 hasAuthorship W2290428590A5073796163 @default.
• W2290428590 hasAuthorship W2290428590A5078103055 @default.
• W2290428590 hasBestOaLocation W22904285901 @default.
• W2290428590 hasConcept C121608353 @default.
• W2290428590 hasConcept C126322002 @default.
• W2290428590 hasConcept C134306372 @default.
• W2290428590 hasConcept C159654299 @default.
• W2290428590 hasConcept C185592680 @default.
• W2290428590 hasConcept C195616568 @default.
• W2290428590 hasConcept C197336794 @default.
• W2290428590 hasConcept C202751555 @default.
• W2290428590 hasConcept C203014093 @default.
• W2290428590 hasConcept C2776194525 @default.
• W2290428590 hasConcept C2777325958 @default.
• W2290428590 hasConcept C2777389519 @default.
• W2290428590 hasConcept C2779707156 @default.
• W2290428590 hasConcept C2780035454 @default.
• W2290428590 hasConcept C33923547 @default.
• W2290428590 hasConcept C502942594 @default.
• W2290428590 hasConcept C542903549 @default.

• next